VentriPoint Diagnostics (CVE:VPT) Trading 2.4% Higher

VentriPoint Diagnostics Ltd. (CVE:VPTGet Free Report)’s stock price traded up 2.4% during mid-day trading on Thursday . The company traded as high as C$0.22 and last traded at C$0.22. 87,007 shares were traded during trading, a decline of 19% from the average session volume of 107,309 shares. The stock had previously closed at C$0.21.

VentriPoint Diagnostics Trading Up 2.4 %

The business has a fifty day moving average of C$0.22 and a 200-day moving average of C$0.25. The stock has a market capitalization of C$33.72 million, a price-to-earnings ratio of -7.17 and a beta of 0.43. The company has a debt-to-equity ratio of 217.41, a current ratio of 1.17 and a quick ratio of 6.67.

About VentriPoint Diagnostics

(Get Free Report)

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements.

Featured Stories

Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.